Creso Pharma


Core One Labs Inc.

CNSX: COOL


Canadian symbol: COOL.CN
US symbol: CLABF

Currency in CAD

Valuation Measures

Market Cap (intraday) 544.71M
Enterprise Value 346.18M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)15.35
Price/Book (mrq)3.48
Enterprise Value/Revenue 315.85
Enterprise Value/EBITDA 7-4.54

Trading Information

Stock Price History

Beta (5Y Monthly) 3.22
52-Week Change 3103.23%
S&P500 52-Week Change 339.22%
52 Week High 31.7000
52 Week Low 30.2600
50-Day Moving Average 30.9069
200-Day Moving Average 30.9138

Share Statistics

Avg Vol (3 month) 3617.32k
Avg Vol (10 day) 3727.75k
Shares Outstanding 570.97M
Implied Shares Outstanding 6N/A
Float 69.62M
% Held by Insiders 15.42%
% Held by Institutions 12.49%
Shares Short (Apr. 14, 2021) 4265.14k
Short Ratio (Apr. 14, 2021) 40.49
Short % of Float (Apr. 14, 2021) 4N/A
Short % of Shares Outstanding (Apr. 14, 2021) 40.37%
Shares Short (prior month Mar. 14, 2021) 459.74k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Jul. 08, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-547.94%

Management Effectiveness

Return on Assets (ttm)-42.80%
Return on Equity (ttm)-285.15%

Income Statement

Revenue (ttm)2.91M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)64.70%
Gross Profit (ttm)-2.83M
EBITDA -10.18M
Net Income Avi to Common (ttm)-39.62M
Diluted EPS (ttm)-1.4170
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.34M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)4.24M
Total Debt/Equity (mrq)38.54
Current Ratio (mrq)0.67
Book Value Per Share (mrq)0.18

Cash Flow Statement

Operating Cash Flow (ttm)-1.44M
Levered Free Cash Flow (ttm)2.09M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
COOL.CN
Core One Labs
4 months ago
COOL.CN
Core One Labs
5 months ago
COOL.CN
Core One Labs
8 months ago
COOL.CN
Core One Labs
10 months ago
COOL.CN
Core One Labs
10 months ago
COOL.CN
Core One Labs
10 months ago
COOL.CN
Core One Labs
10 months ago
COOL.CN
Core One Labs
11 months ago
COOL.CN
Core One Labs
11 months ago
COOL.CN
Core One Labs
11 months ago
COOL.CN
Core One Labs
11 months ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
1 year ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago
COOL.CN
Core One Labs
2 years ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
5.42%% of Shares Held by All Insider
2.49%% of Shares Held by Institutions
2.63%% of Float Held by Institutions
2Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Core One Labs Inc.


Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer's Disease

Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer’s Disease

VANCOUVER, British Columbia, May 06, 2021 -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the ‚ÄúCompany‚ÄĚ or ‚ÄúCore One‚ÄĚ) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (‚ÄúAkome‚ÄĚ) has commenced the development of its next-generation patent pending psychedelic drug formulation for th... Read More...
World Renowned Physician Joins Core One Labs as Chief Medical Officer

World Renowned Physician Joins Core One Labs as Chief Medical Officer

VANCOUVER, British Columbia, May 05, 2021 -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the ‚ÄúCompany‚ÄĚ or ‚ÄúCore One‚ÄĚ) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (‚ÄúAkome‚ÄĚ), as Chief Medical Officer of the Company. Dr. Ferro will lead the Compan... Read More...
Core One Labs Completes Milestone Acquisition of Akome Biotech

Core One Labs Completes Milestone Acquisition of Akome Biotech

VANCOUVER, British Columbia, May 04, 2021 -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the ‚ÄúCompany‚ÄĚ or ‚ÄúCore One‚ÄĚ) a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce that it has completed the acquisition (the ‚ÄúT... Read More...
Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech

Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech

VANCOUVER, British Columbia, April 29, 2021 -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the ‚ÄúCompany‚ÄĚ), a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce that it has entered into a definitive share purchase agr... Read More...
Core One Labs to Explore Joint Venture with Lobe Sciences for the Clinical Development of Biosynthetic Psilocybin

Core One Labs to Explore Joint Venture with Lobe Sciences for the Clinical Development of Biosynthetic Psilocybin

VANCOUVER, British Columbia, April 28, 2021 -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the ‚ÄúCompany‚Ä̬†or ‚ÄúCore One‚ÄĚ) is pleased to announce it has entered into a letter of intent, dated April 27, 2021,¬†with Lobe Sciences Ltd. (‚ÄúLobe‚ÄĚ) pursuant to which the Company will explore the formation of a joint ... Read More...
Repeat: Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC

Repeat: Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC

VANCOUVER, British Columbia, April 26, 2021 -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the ‚ÄúCompany‚ÄĚ) is pleased to announce its wholly owned subsidiary Vocan, has entered into a Collaborative Research Agreement with the University of British Columbia (‚ÄúUBC‚ÄĚ or the ‚ÄúUniversity‚ÄĚ). Research will be cond... Read More...
Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC

Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC

VANCOUVER, British Columbia, April 24, 2021 -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the ‚ÄúCompany‚ÄĚ) is pleased to announce its wholly owned subsidiary Vocan, has entered into a Collaborative Research Agreement with the University of British Columbia (‚ÄúUBC‚ÄĚ or the ‚ÄúUniversity‚ÄĚ). Research will be cond... Read More...
Core One Labs' Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT

Core One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT

VANCOUVER, British Columbia, April 21, 2021 -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the ‚ÄúCompany‚ÄĚ or ‚ÄĚCore One‚ÄĚ) a life sciences research and technology company¬†focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic-assisted psychotherapy is pleased to an... Read More...
Repeat: Core One Labs Files Application to List its Common Shares on NASDAQ

Repeat: Core One Labs Files Application to List its Common Shares on NASDAQ

VANCOUVER, British Columbia, March 22, 2021 -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (‚ÄúCore One‚ÄĚ or the ‚ÄúCompany‚ÄĚ) is pleased to announce that it has filed an application to list its common shares on the Capital Market tier of The NASDAQ Stock Market LLC (‚ÄúNasdaq‚ÄĚ). Nasdaq is ranked as the second-lar... Read More...
Core One Labs Files Application to List its Common Shares on NASDAQ

Core One Labs Files Application to List its Common Shares on NASDAQ

VANCOUVER, British Columbia, March 20, 2021 -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (‚ÄúCore One‚ÄĚ or the ‚ÄúCompany‚ÄĚ) is pleased to announce that it has filed an application to list its common shares on the Capital Market tier of The NASDAQ Stock Market LLC (‚ÄúNasdaq‚ÄĚ). Nasdaq is ranked as the second-lar... Read More...
Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin

Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin

VANCOUVER, BC / ACCESSWIRE / January 23, 2021 /Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the "Company") is pleased to announce its wholly-owned subsidiary Vocan Biotechnologies Inc. ("Vocan") has assembled the necessary equipment, which will allow the laboratory to commence the process of recombinant produ... Read More...
Leading Microbiologist, Dr. Robert E.W. Hancock Appointed as Executive Chairman of Core One Labs

Leading Microbiologist, Dr. Robert E.W. Hancock Appointed as Executive Chairman of Core One Labs

VANCOUVER, BC / ACCESSWIRE / January 7, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company" or "Core One") is pleased to announce the appointment of Dr. Robert E.W. Hancock as Executive Chairman of the Company, effective January 6, 2021.Dr. Hancock is an internationally renowned academic in Mi... Read More...
Core One Labs Signs Definitive Agreement for Acquisition of Biosynthetic Psilocybin Research Firm Vocan Biotechnologies Inc.

Core One Labs Signs Definitive Agreement for Acquisition of Biosynthetic Psilocybin Research Firm Vocan Biotechnologies Inc.

VANCOUVER, BC / ACCESSWIRE / December 24, 2020 / Core One Labs Inc. (CSE:COOL), (OTC:CLABF), (Frankfurt:LD62), (WKN:A14XHT) (the "Company") is pleased to announce that, further to its press release of October 7, 2020, it has entered into a definitive share purchase agreement (the "Purchase Agreement"), dated December 23, 2020, for the acq... Read More...
Core One Labs Provides Update on Financial Statements and Management Cease Trade Order

Core One Labs Provides Update on Financial Statements and Management Cease Trade Order

VANCOUVER, BC / ACCESSWIRE / July 15, 2020 / Core One Labs Inc. (COOL.CN)(CLABD)(LD62.F)(WKN:A2P8K3) (the "Company"). The Company wishes to advise its valued shareholders that the new management team ("Management") is currently working with its auditor and accountants around the clock to finalize its audited financial statements and the r... Read More...
Core One Labs Requests Management Cease Trade Order for Additional Time to Complete Annual Financial Statements and Related Filings

Core One Labs Requests Management Cease Trade Order for Additional Time to Complete Annual Financial Statements and Related Filings

Vancouver, British Columbia--(Newsfile Corp. - June 9, 2020) -  Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL" or the "Company") announced today that it anticipates additional delays in filing its financial statements for the year ended December 31, 2019 and the related management's discussion and analysis ... Read More...
Core One Labs Announces Private Placement Financing and Non-Binding Letter of Intent to Acquire Medical Clinics

Core One Labs Announces Private Placement Financing and Non-Binding Letter of Intent to Acquire Medical Clinics

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD61) (WKN: A14XHT) (the "Company") is pleased to announce that it has entered into a non-binding letter of intent (the "Letter of Intent"), dated June 4, 2020, with Rejuva Alternative Medicine Research Centre Inc. ("Rejuva")... Read More...
Core One Labs Inc. Announces Cancellation of Loan with Viva Capital Ventures, LLC and Grant of Incentive Stock Options

Core One Labs Inc. Announces Cancellation of Loan with Viva Capital Ventures, LLC and Grant of Incentive Stock Options

Vancouver, British Columbia--(Newsfile Corp. - June 1, 2020) -  Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD61) (WKN: A14XHT) ("COOL") announced that it has cancelled the loan transaction with Viva Capital Ventures, LLC ("Viva"). As previously announced, the Company's wholly owned subsidiary, LDS Development Corporation ("LDS De... Read More...
Core One Labs' Subsidiary Signs Loan for USD$900,000; Also Announces Extension of Filing Deadline for Annual and Interim Financial Statements and MD&A, Settlement of Debts for Shares and Resignation of CFO

Core One Labs’ Subsidiary Signs Loan for USD$900,000; Also Announces Extension of Filing Deadline for Annual and Interim Financial Statements and MD&A, Settlement of Debts for Shares and Resignation of CFO

Vancouver, British Columbia--(Newsfile Corp. - April 29, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL") announces that its wholly owned subsidiary, LDS Development Corporation, has entered into an agreement with Viva Capital Ventures LLC ("Viva") for a secured loan for USD$900,000 (the "Loan"). The... Read More...
Core One Labs' Subsidiary, Core Isogenics Inc., Completes 7th and 8th Harvests of Top Grade Flower at the Adelanto Indoor Grow

Core One Labs’ Subsidiary, Core Isogenics Inc., Completes 7th and 8th Harvests of Top Grade Flower at the Adelanto Indoor Grow

Vancouver, British Columbia--(Newsfile Corp. - February 19, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL") announces that its wholly-owned subsidiary, Core Isogenics Inc., has completed its seventh and eighth consecutive harvests at the Adelanto facility.The Core Isogenics' nursery and cultivation ... Read More...
Core One Labs' Subsidiary, Core Isogenics Inc., in Association with Reiziger Pty. Ltd. Begins to Show Strong Results

Core One Labs’ Subsidiary, Core Isogenics Inc., in Association with Reiziger Pty. Ltd. Begins to Show Strong Results

Vancouver, British Columbia--(Newsfile Corp. - February 18, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD61) (WKN: A14XHT) ("COOL") announces that its wholly-owned subsidiary, Core Isogenics Inc., has begun a highly complex nutritional regimen to accelerate the growth of cannabis plants and increase flower yield and quali... Read More...
Core One Labs Inc. Subsidiary, CSPA Group, Inc., Continues to Expand Extraction Capabilities with White Label and Wholesale Products

Core One Labs Inc. Subsidiary, CSPA Group, Inc., Continues to Expand Extraction Capabilities with White Label and Wholesale Products

Vancouver, British Columbia--(Newsfile Corp. - January 28, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL") announces that its wholly-owned subsidiary, CSPA Group, Inc. ("CSPA"), continues to expand its extraction capability using Color Remediation Technology ("CRT").CSPA has expanded production to a... Read More...
Core One Labs' Rêveur Brand is Gaining Consumer Traction with its High Yield In-House Product

Core One Labs’ R√™veur Brand is Gaining Consumer Traction with its High Yield In-House Product

Vancouver, British Columbia--(Newsfile Corp. - January 23, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL") is pleased to see an increase in demand for Rêveur branded product being produced in its Adelanto facility.Rêveur live Resin and Indoor Flower is currently being sold through the Company's dist... Read More...
Core One Labs' Subsidiary, Core Isogenics Inc., Completes Second and Third Harvests of Top Grade Flower at the Adelanto Indoor Grow

Core One Labs’ Subsidiary, Core Isogenics Inc., Completes Second and Third Harvests of Top Grade Flower at the Adelanto Indoor Grow

VANCOUVER, British Columbia, Jan. 3, 2020 -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL") announces that its wholly-owned subsidiary, Core Isogenics Inc., has completed its second and third on-going harvests at the Adelanto facility. The second and the third harvests comprised approximately 20% of... Read More...
Core One Labs Inc.'s Subsidiary, Core Isogenics Inc., Completes its First Indoor Harvest

Core One Labs Inc.’s Subsidiary, Core Isogenics Inc., Completes its First Indoor Harvest

VANCOUVER, British Columbia, Dec. 20, 2019 -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL") announces that its subsidiary, Core Isogenics Inc., has harvested 345 pounds of flower from its indoor facility at 9501 Commerce Way in Adelanto. This is the first harvest from the facility and accounted for... Read More...
Core One Labs' Subsidiary, Core Isogenics Inc., Begins Harvesting Indoor Grow

Core One Labs’ Subsidiary, Core Isogenics Inc., Begins Harvesting Indoor Grow

VANCOUVER, British Columbia, Dec. 17, 2019 -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL") announces that its wholly-owned subsidiary, Core Isogenics Inc., has begun its first harvest at the 9501 Commerce Way facility in Adelanto California. The Core Isogenics nursery facility and the cultivation ... Read More...
Core One Labs' Subsidiary, Core Isogenics Inc., Teams up with Reiziger Pty. Ltd. to Showcase High Yielding Nutritional Cultivation Technology

Core One Labs’ Subsidiary, Core Isogenics Inc., Teams up with Reiziger Pty. Ltd. to Showcase High Yielding Nutritional Cultivation Technology

VANCOUVER, British Columbia, Dec. 9, 2019 -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL") announces that its wholly-owned subsidiary, Core Isogenics Inc., has begun a highly complex nutritional regimen to accelerate the growth of cannabis plants and increase flower yield and quality. The Core Iso... Read More...
Core One Labs Announces Q3 2019 Financial Results and Provides Corporate Update

Core One Labs Announces Q3 2019 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia , Dec. 4, 2019 -- Core One Labs Inc. (COOL.CN), (CLABF), ( Frankfurt : LD6, WKN: A14XHT) ("COOL") announces that the Company has filed its financial statements and MD&A for the three and nine month periods ended September 30, 2019 , and provides an update on the corporate milestones achieved during the quar... Read More...
Core One Labs Inc. has Filed a Trademark Application with WIPO Madrid for an Additional Trademark

Core One Labs Inc. has Filed a Trademark Application with WIPO Madrid for an Additional Trademark

VANCOUVER, British Columbia, Dec. 3, 2019 --¬†Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL") announces that it has filed a Trademark Application with WIPO Madrid to trademark "CBDSTRIPS" in the United Kingdom, Germany and Spain. This is in addition to its CannaStrips‚ĄĘ¬†filings. The filing of additiona... Read More...
Core One Labs' Subsidiary, Core Isogenics Inc., Flowering Room is Now Operational and Anticipating its First Harvest

Core One Labs’ Subsidiary, Core Isogenics Inc., Flowering Room is Now Operational and Anticipating its First Harvest

VANCOUVER, British Columbia, Nov. 27, 2019 -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL") announces that its wholly-owned subsidiary, Core Isogenics Inc., has completed multiple transfers (approximately 6,400 seedlings) from the vegetation room to the flowering room. Core Isogenics' flowering roo... Read More...
Core One Labs' Subsidiary, Agrotech LLC, Completes 1,600 Pound Harvest of Sacramento Farm

Core One Labs’ Subsidiary, Agrotech LLC, Completes 1,600 Pound Harvest of Sacramento Farm

VANCOUVER, British Columbia, Nov. 21, 2019 -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL") announces that its 50%-owned subsidiary, Agrotech LLC, has harvested 1,600 pounds from the Sacramento farm it manages and has completed drying and testing of the biomass. Agrotech LLC has harvested a section... Read More...
Core One Labs Inc. Closes Agreement to Acquire Micro-Cultivation Facility in Canada

Core One Labs Inc. Closes Agreement to Acquire Micro-Cultivation Facility in Canada

VANCOUVER, British Columbia, Nov. 18, 2019 -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL") announces it has completed the acquisition of Rainy Daze Cannabis Corp ("Rainy Daze") by purchasing all issued and outstanding shares of Rainy Daze in exchange for $100,000 cash and by issuing an aggregate o... Read More...
Coming Soon.
SymbolExchangePriceChangeAs of
COOL.CD
Canadian Securities Exchange - CSE Listed
Canadian Securities Exchange - CSE Listed0.63CAD-3.08%
LD62.F
Frankfurt Stock Exchange
Frankfurt Stock Exchange0.41EUR-5.07%
COOL.CCP
Canadian Composite Quote/Trade
Canadian Composite Quote/Trade0.65CAD-2.99%
LD62.BE
Berlin Stock Exchange
Berlin Stock Exchange0.41EUR-3.73%
CLABF.PK
US 'Other OTC' and Grey Market
US 'Other OTC' and Grey Market0.50USD-6.87%
LD62.MU
Munich Stock Exchange
Munich Stock Exchange0.42EUR-4.32%
LD62.SG
Stuttgart Stock Exchange
Stuttgart Stock Exchange0.40EUR-11.38%
CLABF.PQ
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L20.50USD-5.75%

Delayed data (1h)
NameAgePositionAppointed
Robert E. W. Hancock
Executive Chairman of the Board
--Executive Chairman of the Board2021
Casey Fenwick
President
--President2019
Joel Shacker
Chief Executive Officer
--Chief Executive Officer2020
Geoff Balderson
Chief Financial Officer, Secretary
39Chief Financial Officer, Secretary2020
John Sanderson
Chief Scientific Officer
67Chief Scientific Officer2016
Ryan Hoggan
Director
--Director2020
Patrick Morris
Independent Director
51Independent Director2020


Share this page